secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001493152-26-021329
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pure Bioscience raises $1.0M in private placement at $0.0553/share; directors invest
--------------------------------------------------------------------------------

- Closed private placement of 18,131,096 shares at $0.0553/share for $1.0M gross.
- Director Tom Y. Lee invested ~$700,000; director Ivan Chen invested $27,650.
- Net proceeds ~$1.0M for R&D, working capital, and general corporate purposes.
- Shares sold to accredited investors under Section 4(a)(2)/Reg D exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315226021329/0001493152-26-021329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315226021329/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-021329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer